PURPOSE: The chemokine receptor CXCR4 plays a role in the metastasis and progression of a broad range of malignant tumors; however, its influence on hepatocellular carcinoma (HCC) is not well defined. Thus, we analyzed the expression of CXCR4 and its functions in HCC cell lines in vitro. MATERIALS AND METHODS: Five HCC cell lines (HepG2, Hep3B, SK-HEP-1, NCI-H630 and PLC/PRF5) were investigated. The CXCR4 expression was analyzed by RT-PCR, Western blotting, flow cytometry and immunofluorescence staining. In addition, the effects of stromal cell-derived factor-1 (SDF-1) on the migration, proliferation and survival of the cells were investigated, as well as the SDF-1-induced phosphorylation of signaling molecules. RESULTS: All five cell lines had abundant CXCR4 in their cytoplasm, whereas a cell surface CXCR4 expression was only detected in a very small population of PLC/PRF5 cells. In contrast, SDF-1 bound to all the cells. SDF-1 induced the phosphorylation of AKT and ERK1/2 in the PLC/PRF5 cells and the phosphorylation of Stat3, AKT and ERK1/2 in the Hep3B cells. Nonetheless, SDF-1 did not induce migration or proliferation in any of the cells, nor did it rescue the cells from serum deprivation-induced apoptosis. Recruitment of CXCR4 from the cytoplasm to the cell surface was not elicited by dexamethasone, proinflammatory cytokines or VEGF. Hypoxia increased both the cytoplasmic and cell surface expressions of CXCR4 in only the PLC/PRF5 cells. CONCLUSIONS: CXCR4 is trapped in the cytoplasm and it is not recruited to the cell surface by standard extrinsic stimuli in the majority of HCC cell lines, and the result of this is a negligible response to SDF-1.
PURPOSE: The chemokine receptor CXCR4 plays a role in the metastasis and progression of a broad range of malignant tumors; however, its influence on hepatocellular carcinoma (HCC) is not well defined. Thus, we analyzed the expression of CXCR4 and its functions in HCC cell lines in vitro. MATERIALS AND METHODS: Five HCC cell lines (HepG2, Hep3B, SK-HEP-1, NCI-H630 and PLC/PRF5) were investigated. The CXCR4 expression was analyzed by RT-PCR, Western blotting, flow cytometry and immunofluorescence staining. In addition, the effects of stromal cell-derived factor-1 (SDF-1) on the migration, proliferation and survival of the cells were investigated, as well as the SDF-1-induced phosphorylation of signaling molecules. RESULTS: All five cell lines had abundant CXCR4 in their cytoplasm, whereas a cell surface CXCR4 expression was only detected in a very small population of PLC/PRF5 cells. In contrast, SDF-1 bound to all the cells. SDF-1 induced the phosphorylation of AKT and ERK1/2 in the PLC/PRF5 cells and the phosphorylation of Stat3, AKT and ERK1/2 in the Hep3B cells. Nonetheless, SDF-1 did not induce migration or proliferation in any of the cells, nor did it rescue the cells from serum deprivation-induced apoptosis. Recruitment of CXCR4 from the cytoplasm to the cell surface was not elicited by dexamethasone, proinflammatory cytokines or VEGF. Hypoxia increased both the cytoplasmic and cell surface expressions of CXCR4 in only the PLC/PRF5 cells. CONCLUSIONS:CXCR4 is trapped in the cytoplasm and it is not recruited to the cell surface by standard extrinsic stimuli in the majority of HCC cell lines, and the result of this is a negligible response to SDF-1.
Authors: A Peled; I Petit; O Kollet; M Magid; T Ponomaryov; T Byk; A Nagler; H Ben-Hur; A Many; L Shultz; O Lider; R Alon; D Zipori; T Lapidot Journal: Science Date: 1999-02-05 Impact factor: 47.728
Authors: Matthew C P Smith; Kathryn E Luker; Joel R Garbow; Julie L Prior; Erin Jackson; David Piwnica-Worms; Gary D Luker Journal: Cancer Res Date: 2004-12-01 Impact factor: 12.701
Authors: Andrew C W Zannettino; Amanda N Farrugia; Angela Kortesidis; Jim Manavis; L Bik To; Sally K Martin; Peter Diamond; Hirokazu Tamamura; Tsvee Lapidot; Nobutaka Fujii; Stan Gronthos Journal: Cancer Res Date: 2005-03-01 Impact factor: 12.701
Authors: Jennifer M Burns; Bretton C Summers; Yu Wang; Anita Melikian; Rob Berahovich; Zhenhua Miao; Mark E T Penfold; Mary Jean Sunshine; Dan R Littman; Calvin J Kuo; Kevin Wei; Brian E McMaster; Kim Wright; Maureen C Howard; Thomas J Schall Journal: J Exp Med Date: 2006-08-28 Impact factor: 14.307
Authors: C C Schimanski; R Bahre; I Gockel; A Müller; K Frerichs; V Hörner; A Teufel; N Simiantonaki; S Biesterfeld; T Wehler; M Schuler; T Achenbach; T Junginger; P R Galle; M Moehler Journal: Br J Cancer Date: 2006-07-04 Impact factor: 7.640
Authors: Megan M Harper; Miranda Lin; Michael J Cavnar; Prakash K Pandalai; Reema A Patel; Mei Gao; Joseph Kim Journal: PLoS One Date: 2022-07-07 Impact factor: 3.752
Authors: Ismael Ghanem; Maria E Riveiro; Valerie Paradis; Sandrine Faivre; Paula M Vázquez de Parga; Eric Raymond Journal: Am J Transl Res Date: 2014-07-18 Impact factor: 4.060
Authors: Caterina Ierano; Agnes Basseville; Kenneth K W To; Zhirong Zhan; Robert W Robey; Julia Wilkerson; Susan E Bates; Stefania Scala Journal: Cancer Biol Ther Date: 2012-11-28 Impact factor: 4.742
Authors: Maria Neve Polimeno; Caterina Ierano; Crescenzo D'Alterio; Nunzia Simona Losito; Maria Napolitano; Luigi Portella; Giosuè Scognamiglio; Fabiana Tatangelo; Anna Maria Trotta; Steven Curley; Susan Costantini; Raffaele Liuzzi; Francesco Izzo; Stefania Scala Journal: Cell Mol Immunol Date: 2014-11-03 Impact factor: 11.530
Authors: Rebecca A Pelekanos; Michael J Ting; Varda S Sardesai; Jennifer M Ryan; Yaw-Chyn Lim; Jerry K Y Chan; Nicholas M Fisk Journal: BMC Cell Biol Date: 2014-05-16 Impact factor: 4.241